IO Biotech, Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
IOBT on Nasdaq
Industry
Pharmaceutical Preparations
Location
Ole Maaloes Veh 3, Copenhagen, Denmark

Insiders trading volume in the past year

IO Biotech, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Lundbeckfond Invest A/S Director, 10%+ Owner $14.4M Aug 9, 2023
Christian Elling Director $14.4M Jun 6, 2024
Vivo Capital IX, LLC 10%+ Owner $9.51M Aug 9, 2023
Novo Holdings A/S 10%+ Owner $5.71M -$1.89M -24.9% Jul 25, 2024
HBM Healthcare Investments (Cayman) Ltd. 10%+ Owner $2.78M Nov 9, 2021
Claus Andersson Director $1.85M Nov 9, 2021
Kurma Partners 10%+ Owner $645K Aug 9, 2023
Vanessa Malier Director $446K Nov 9, 2021
Amy Sullivan Chief Financial Officer $77K Mar 15, 2024
Mai-Britt Zocca Chief Executive Officer, Director $66.2K Mar 15, 2024
Brian Burkavage Chief Accounting Officer $11.9K +$5.18K +76.9% Mar 15, 2024
Devin W. Smith General Counsel $5.11K Mar 15, 2024
Priyanka Belawat Director Nov 4, 2021
Jack Nielsen Director Jun 8, 2023
Heidi Hunter Director Jun 6, 2024
Kathleen Sereda Glaub Director Jun 6, 2024
Keith Vendola Chief Financial Officer Nov 4, 2021
Qasim Ahmad Chief Medical Officer Mar 15, 2024
Helen Louise Collins Director Jun 6, 2024
Muhammad Al-Hajj Chief Scientific Officer Mar 20, 2023
Eva Ehrnrooth Chief Medical Officer Mar 20, 2023
Peter Hirth Director Jun 6, 2024
Emmanuelle Coutanceau Director Nov 4, 2021
David V. Smith Director Jun 6, 2024

Recent Insider Transactions by Companies or Individuals for IO Biotech, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.